» Articles » PMID: 26693205

Inflammation and Oxidative Stress: The Molecular Connectivity Between Insulin Resistance, Obesity, and Alzheimer's Disease

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2015 Dec 23
PMID 26693205
Citations 171
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes (T2DM), Alzheimer's disease (AD), and insulin resistance are age-related conditions and increased prevalence is of public concern. Recent research has provided evidence that insulin resistance and impaired insulin signalling may be a contributory factor to the progression of diabetes, dementia, and other neurological disorders. Alzheimer's disease (AD) is the most common subtype of dementia. Reduced release (for T2DM) and decreased action of insulin are central to the development and progression of both T2DM and AD. A literature search was conducted to identify molecular commonalities between obesity, diabetes, and AD. Insulin resistance affects many tissues and organs, either through impaired insulin signalling or through aberrant changes in both glucose and lipid (cholesterol and triacylglycerol) metabolism and concentrations in the blood. Although epidemiological and biological evidence has highlighted an increased incidence of cognitive decline and AD in patients with T2DM, the common molecular basis of cell and tissue dysfunction is rapidly gaining recognition. As a cause or consequence, the chronic inflammatory response and oxidative stress associated with T2DM, amyloid-β (Aβ) protein accumulation, and mitochondrial dysfunction link T2DM and AD.

Citing Articles

Trends in Alzheimer's-Related Mortality Among Type 2 Diabetes Patients in the United States: 1999-2019.

Waqas S, Ali D, Khan T, Qureshi S, Siddiqui H, Sajid M Endocrinol Diabetes Metab. 2025; 8(2):e70032.

PMID: 39899444 PMC: 11789764. DOI: 10.1002/edm2.70032.


Construction of a Dataset for All Expressed Transcripts for Alzheimer's Disease Research.

Huang Z, Shi B, Mu X, Qiao S, Xiao G, Wang Y Brain Sci. 2025; 14(12.

PMID: 39766379 PMC: 11674848. DOI: 10.3390/brainsci14121180.


Therapeutic agents for Alzheimer's disease: a critical appraisal.

Weinstock M Front Aging Neurosci. 2024; 16:1484615.

PMID: 39717349 PMC: 11663918. DOI: 10.3389/fnagi.2024.1484615.


Causal relationships between Alzheimer's disease and metabolic dysfunction associated with fatty liver disease: insights from bidirectional network Mendelian Randomization analysis.

Liu L, Zhou M, Zhang Y, Chen Y, Wang H, Cao Y Metabolomics. 2024; 21(1):4.

PMID: 39673021 DOI: 10.1007/s11306-024-02193-0.


Low sucrose diets protect long-term memory and EPA & DHA enriched diets alter insulin resistance in a mouse model of chemotherapy.

Ormiston K, Fitzgerald J, Andridge R, Lustberg M, DeVries A, Orchard T Nutr Res. 2024; 131:39-53.

PMID: 39368285 PMC: 11683824. DOI: 10.1016/j.nutres.2024.09.004.


References
1.
Kurz G, Wiesinger H, Hamprecht B . Purification of cytosolic malic enzyme from bovine brain, generation of monoclonal antibodies, and immunocytochemical localization of the enzyme in glial cells of neural primary cultures. J Neurochem. 1993; 60(4):1467-74. DOI: 10.1111/j.1471-4159.1993.tb03309.x. View

2.
Konner A, Janoschek R, Plum L, Jordan S, Rother E, Ma X . Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007; 5(6):438-49. DOI: 10.1016/j.cmet.2007.05.004. View

3.
Rosenstraus M, Chasin L . Isolation of mammalian cell mutants deficient in glucose-6-phosphate dehydrogenase activity: linkage to hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci U S A. 1975; 72(2):493-7. PMC: 432338. DOI: 10.1073/pnas.72.2.493. View

4.
Taniguchi C, Emanuelli B, Kahn C . Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006; 7(2):85-96. DOI: 10.1038/nrm1837. View

5.
Jacobson J, Duchen M . Interplay between mitochondria and cellular calcium signalling. Mol Cell Biochem. 2004; 256-257(1-2):209-18. DOI: 10.1023/b:mcbi.0000009869.29827.df. View